1300696-19-8

Basic information

• Product Name: methyl 4-[(2S,4R)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate
• Synonyms: methyl 4-[(2S,4R)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate
• CAS NO: 1300696-19-8
• Molecular Weight: 352.433
• Mol File: 1300696-19-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 4-[(2S,4R)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-[(2S,4R)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate(1300696-19-8)
• EPA Substance Registry System: methyl 4-[(2S,4R)-1-acetyl-4-amino-2-methyl-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate(1300696-19-8)

Safety Data

• Hazardous Substances Data: 1300696-19-8(Hazardous Substances Data)

Upstream product

• 1300031-92-8 (3S)-3-[(4-bromophenyl)amino]butanenitrile 
• 1300031-93-9 (3S)-3-[(4-bromophenyl)amino]butanamide 
• 1300031-94-0 1-methylethyl {(3S)-3-[(4-bromophenyl)amino]butanoyl}carbamate 
• 1300031-95-1 1-methylethyl [(2S,4R)-6-bromo-2-methyl-1,2,3,4-tetrahydro-4-quinolinyl]carbamate 
• 106-40-1 4-bromo-aniline 
• 1300031-98-4 1-methylethyl [(2S,4R)-1-acetyl-6-bromo-2-methyl-1,2,3,4-tetrahydro-4-quinolinyl]carbamate 
• 1300696-22-3 methyl 4-[(2S,4R)-1-acetyl-2-methyl-4-({[(1-methylethyl)oxy]carbonyl}amino)-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate 
• 680188-22-1 (S)-3-(N-phenylamino)-butyronitrile 
• 108-86-1 bromobenzene 

Downstream Products

• 1300694-36-3 methyl 4-[(2S,4R)-1-acetyl-2-methyl-4-(3-pyridinylamino)-1,2,3,4-tetrahydro-6-quinolinyl]-3-methylbenzoate 
• 1300694-33-0 4-[(2S,4R)-1-acetyl-2-methyl-4-(3-pyridinylamino)-1,2,3,4-tetrahydro-6-quinolinyl]-3-methyl benzoic acid 

Relevant articles and documents

THETRAHYDROQUINOLINES DERIVATIVES AS BROMODOMAIN INHIBITORS

Tetrahydroquinoline compounds of formula (I) or a salt thereof, pharmaceutical compositions containing such compounds and their use in therapy, in particular in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.